Adina Turcu
LightNews LightNews
adinaturcu.bsky.social
Adina Turcu
@adinaturcu.bsky.social
44 followers 39 following 3 posts
Posts Replies Media Videos
Reposted by Adina Turcu
nejm.org
BaxHTN phase 3 trial: Aldosterone dysregulation is considered a key driver of hard-to-control hypertension. Research findings on baxdrostat, a highly selective, potent aldosterone synthase inhibitor, in hard-to-control hypertension are summarized in a new Quick Take video. nej.md/3KCsQGJ
A visual representation of the BaxHTN phase 3 trial, which evaluated baxdrostat, a highly selective, potent aldosterone synthase inhibitor, in patients with hard-to-control hypertension.
October 15, 2025 at 7:02 PM
Reposted by Adina Turcu
esendocrinology.bsky.social
Following the ESE Executive Committee meeting in Munich last week, members of the ESE leadership team were delighted to be invited to the retirement lecture for Martin Reincke, Past-President of ESE, at @lmumuenchen.bsky.social. We wish Martin all the best in his next chapter.
#OurEndocrineCommunity
October 13, 2025 at 3:35 PM
Reposted by Adina Turcu
nejm.org
New in the October 9, 2025, issue of NEJM:

Baxdrostat Efficacy and Safety in Uncontrolled Hypertension (BaxHTN phase 3 trial) nej.md/4my7xUZ

Nexiguran Ziclumeran in ATTR with Polyneuropathy nej.md/46Qhur7

#MedSky
Images and descriptions of what's new on NEJM.org this week  
October 9, 2025 at 1:03 PM
Reposted by Adina Turcu
endocrinesociety.bsky.social
Endocrine Feedback Loop | Listen to Oksana Hamidi, DO, MSCS, and Jill Wagoner, MD, discuss a recent #JCEM article (http://bit.ly/4pC3BEl)on mild autonomous cortisol secretion (MACS) is associated with increased risk of vertebral fractures (VFx) (https://bit.ly/EFL065)
September 27, 2025 at 2:45 PM
Reposted by Adina Turcu
drwanpen.bsky.social
Got to Baltimore #Hypertension25 so excited to see friends and colleagues talking about high BP ! @ahascience.bsky.social @giaconajohn.bsky.social
September 3, 2025 at 9:15 PM
Reposted by Adina Turcu
eurojendo.bsky.social
A global real-world study assessing total time to adrenalectomy in primary aldosteronism by Charmaine Ter et al

EJE Volume 193, Issue 1, July 2025
Open access article 👉 doi.org/10.1093/ejen...

#endocrinology #adrenalectomy #aldosteronism
August 28, 2025 at 2:12 PM
Reposted by Adina Turcu
endocrinesociety.bsky.social
Watch our videos with Annual Meeting Steering Committee Chair (AMSC) Gisella Carranza Leon, MD, on creation of ENDO programming and how submitting a session idea can help you in your career. She provides insight in English (bit.ly/3UOXNJB) and Español (bit.ly/47RuYUz). #ENDO2026 #endocrinology
Gisella Carranza Leon, MD | ENDO 2026 Session Submissions
Annual Meeting Steering Committee Chair (AMSC) Gisella Carranza Leon, MD, discusses how submitting a session idea can help you in your career. She also provides insight on how the AMSC uses session ideas to create ENDO programming. Submit your session suggestions and symposia proposals by Tuesday, September 2: https://bit.ly/4flCMjl #ENDO2026
bit.ly
August 27, 2025 at 8:44 PM
adinaturcu.bsky.social
#ENDO2026 Welcomes Your Ideas | Our annual meeting will take place in Chicago, IL, June 13–16, and I’m inviting YOU to shape the program💡Submit your symposium proposal or session suggestion by Tuesday, September 2: bit.ly/4flCMjl
#endocrinology @TheEndoSociety
ENDO 2026 Session Submissions
ENDO wouldn’t be possible without the insight and expertise of the Endocrine community. Your ideas are essential to building a dynamic, forward-thinking program that reflects the full breadth of our f...
bit.ly
August 28, 2025 at 4:35 PM
Reposted by Adina Turcu
drwanpen.bsky.social
Join us @jordybc.bsky.social , Keith Ferdinand, and Dan Jones unpacking 2025 AHA/ACC guidelines on Thursday Aug 28 bit.ly/Guideline25W... @UTSWInternalMed @utswheart
August 19, 2025 at 11:39 PM
Reposted by Adina Turcu
endocrinesociety.bsky.social
“Diabetes and Pregnancy” has been long anticipated. For the first time, clinicians will have a definitive guide on treating these patients that now includes the most recent technological breakthroughs in diabetes treatments. Read more in @endocrinenews.bsky.social: bit.ly/45FR4rx #endocrinology
Redefining Diabetes Care in Pregnancy - Endocrine News
New Endocrine Society and European Endocrine Society guidelines provide a much-needed update Making its debut at ENDO 2025, “Diabetes and Pregnancy: An Endocrine Society and European Society of Endocr...
bit.ly
August 7, 2025 at 8:57 PM
Reposted by Adina Turcu
nejm.org
Shalender Bhasin, MB, BS, and Peter J. Snyder, MD, review available data on the benefits and risks of testosterone treatment in middle-aged and older men with moderate hypogonadism. Learn more in a new Review Article: nej.md/4ooeFo7

#MedSky #EndoSky #Urology
Review Article Testosterone Treatment in Middle-Aged and Older Men with Hypogonadism An illustrated diagram showing the pathways mediating the physiological and clinical effects of testosterone in men.
August 6, 2025 at 10:01 PM
Reposted by Adina Turcu
anandvaidya17.bsky.social
New Primary Aldosteronism Guidelines - simpler, streamlined, and hopefully more pragmatic
academic.oup.com/jcem/advance...
July 15, 2025 at 1:06 PM
Reposted by Adina Turcu
a5-adrenal.bsky.social
A5 meeting under way in San Francisco, led by our executive chair Dr Habra.
#adrenal
July 15, 2025 at 8:01 PM
Reposted by Adina Turcu
garydouglashammer.bsky.social
@lmfendo.bsky.social at @endocrinesociety.bsky.social #ENDO2025 presents new data on modifier genes in paraganglioma-pheochromocytoma from GWAS studies with close to 2000 tumor samples from @a5-adrenal.bsky.social teams around the globe. New targets, new biology. Hope for new therapies!
July 15, 2025 at 5:28 PM
Reposted by Adina Turcu
endocrinesociety.bsky.social
Editor-in-Chief @zane-andrews.bsky.social will be chairing our #Endocrinology Journal Symposium at 8:00 AM in Room 308 to examine GLP-1-based therapies and the emergence of GLP-1-based multi-agonists combining with other hormones: bit.ly/4lMdrku #ENDO2025
@endosocjournals.bsky.social
ENDO25
bit.ly
July 15, 2025 at 2:35 PM
Reposted by Adina Turcu
drwanpen.bsky.social
New PA Endo guideline is also out by experts @anandvaidya17.bsky.social #Cardiosky @hswapnil.medsky.social doi.org/10.1210/clin...
Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
AbstractBackground. Primary aldosteronism (PA), a primary adrenal disorder leading to excessive aldosterone production by one or both adrenal glands, is a
doi.org
July 14, 2025 at 6:56 PM
Reposted by Adina Turcu
endocrinesociety.bsky.social
Get ready for the third day of ENDO | It was great seeing everyone yesterday for a day full of science! We cannot wait to host you tomorrow. Join us for a wide range of networking events. View our program planner and mark your schedule: bit.ly/4nJotbW
July 14, 2025 at 12:59 AM
Reposted by Adina Turcu
hswapnil.medsky.social
A medical adrenalectomy?

ASIs advance - Baxdrostat in primary aldosteronism now www.nejm.org/doi/full/10.... n = 15 single arm trial from @adinaturcu.bsky.social and @astra-zeneca.bsky.social in @nejm.org

~ 25/10 mm Hg BP lowering and impressive aldosterone level drop

#Hypertension #EndoSky
Efficacy and Side-Effect Profile of Baxdrostat in Patients with Primary Aldosteronism.
July 14, 2025 at 11:03 AM
Reposted by Adina Turcu
anastasiasmihaili.bsky.social
Congratulations @adinaturcu.bsky.social & co-authors 👏👏

Exciting time for 🔦 on the equally important second “A” in #RAAS 😁
hswapnil.medsky.social Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · Jul 14
A medical adrenalectomy?

ASIs advance - Baxdrostat in primary aldosteronism now www.nejm.org/doi/full/10.... n = 15 single arm trial from @adinaturcu.bsky.social and @astra-zeneca.bsky.social in @nejm.org

~ 25/10 mm Hg BP lowering and impressive aldosterone level drop

#Hypertension #EndoSky
Efficacy and Side-Effect Profile of Baxdrostat in Patients with Primary Aldosteronism.
July 14, 2025 at 12:27 PM
Reposted by Adina Turcu
garydouglashammer.bsky.social
Outstanding talk here at @endocrineoncology.bsky.social #ENDO2025 on adrenal Cushing genomics by University of Michigan adrenal team member Juilee Rege here at #ENDO2025. Go Juilee, Go Blue, Go @A5-Alliance
July 13, 2025 at 12:11 AM
Reposted by Adina Turcu
nejm.org
In 15 patients with primary aldosteronism, baxdrostat (a second-generation, nonimidazole aldosterone synthase inhibitor) resolved or reduced the severity of hypertension, excessive aldosterone production, and hypokalemia. Full SPARK study results: nej.md/40Js1kz

#ENDO2025
A figure showing the changes from baseline in systolic blood pressure (SBP), plasma aldosterone–renin ratio (ARR), and serum potassium level for each patient.
July 13, 2025 at 10:06 PM
Reposted by Adina Turcu
esendocrinology.bsky.social
Join us! ESE Talks...Rare Diseases - CAH; diagnostic and therapeutic challenges across the entire lifespan - A joint webinar with ESE, Endo-ERN and ESPE.

📅 2 September, 17:00-18:30 CEST

Register for free 👉 ow.ly/I29350W2XNp
#RareDiseases #CAH #Endocrinology
July 10, 2025 at 1:55 PM
Reposted by Adina Turcu
nadfadrenal.bsky.social
Accurate steroid replacement is essential for children with adrenal insufficiency, but giving medication to kids can be a game of cat and mouse. Hydrocortisone granules are a game changer. Read more: NADF.us/children-with-adrenal-insufficiency

#AADAM2025 #AdrenalDiseaseAwareness #AdrenalDisease
Hexagonal photo of small child running away. Text reads, "Tricky customer? Try hydrocortisone granules! Accurate steroid replacement dosing is imperative to health in children and infants with adrenal insufficiency. ALKINDI SPRINKLE is a granular version of hydrocortisone developed and approved for the treatment of adrenal insufficiency in newborns and children: small enough to sprinkle onto soft food, like yogurt or applesauce, or directly into your child’s mouth. Read more on treating adrenal insufficiency in children: NADF.us/children-with-adrenal-insufficiency. #AADAM2025 April is Adrenal Disease Awareness Month. NADF.us/april-calendar."
April 16, 2025 at 7:47 PM
Reposted by Adina Turcu
nadfadrenal.bsky.social
Register today for the Adrenal Disease Awareness Month Webinar with #AAES and #NADFAdrenal. We are excited to bring you this annual event as part of #AADAM2025.

April 10, 2025 - 8pm EST / 5pm PST
Visit bit.ly/AAES-NADF to register
Coming soon! Adrenal Disease Awareness Month Webinar. Thursday, April 10, 2025. 8:00PM EST (5:00PM EST). Register today: bit.ly/AAES-NADF #AADAM2025 April Is Adrenal Disease Awareness month. NADF.us/april-calendar. Headshots of Dr. Paul Graham, Dr. Amir Hamrahian, Dr. Philip Smith, and Dr. Carmen Solórzano, and moderators Dr. Lilah Morris-Wiseman and Dr. Susana Vargas Pinto.
April 4, 2025 at 7:21 PM